DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis
Qian Yin(Jiangnan University), Jingjing Li(Weifang Medical University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Yiwen Zhang(Sichuan University), Jia Wu(Zhejiang Cancer Hospital), Hui Zeng(Dalian Medical University), Jiaojiao Ni(Zhejiang Cancer Hospital), Wei Zhuo(Women's Hospital, School of Medicine, Zhejiang University), Yu Yao(First Affiliated Hospital of Xi'an Jiaotong University), Wei Wu(Chinese Academy of Sciences)
Cited by 21
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412